Form 4: AnaptysBio CEO Daniel Faga Sells Shares to Cover Tax Obligations

AnaptysBio CEO Daniel Faga sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).

Summary

• On March 22, 2024, Daniel Faga, CEO of AnaptysBio, Inc., sold 752,087 shares of common stock at a price of $22.7846.
• On March 25, 2024, Faga sold 3,000 shares of common stock at a price of $21.4225.
• On March 26, 2024, 347,441 shares were withheld by the issuer to satisfy tax obligations.
• Following these transactions, Faga directly owns 401,646 shares of AnaptysBio common stock.
• The sales were executed to cover tax withholding obligations associated with the vesting of RSUs and do not represent discretionary transactions.

Sentiment

Score: 5

Explanation: The document reflects routine transactions to cover tax obligations, which is neutral in sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future actions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal as the sales were for tax purposes.

Key Dates